• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药大元阴挥发性成分在抗击新冠疫情中的重要作用

The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic.

作者信息

Zhang Xiao-Rui, Li Ting-Na, Ren Yuan-Yuan, Zeng Yi-Jia, Lv Hong-Yang, Wang Jin, Huang Qin-Wan

机构信息

College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Pharmacol. 2020 Sep 25;11:583651. doi: 10.3389/fphar.2020.583651. eCollection 2020.

DOI:10.3389/fphar.2020.583651
PMID:33101037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7546797/
Abstract

Aromatic Chinese herbs have been used to prevent plagues since ancient times. Traditional Chinese medicine has unique advantages in the prevention and treatment of epidemic diseases. According to the traditional Chinese medicine treatment plan in the National COVID-19 Diagnosis and Treatment Plan (Trial Seventh Edition) of the National Health Commission, Chinese patent medicines or prescriptions rich in aromatic Chinese herbs are selected for prevention and treatment during the period of medical observation, clinical treatment, and recovery of confirmed COVID-19 patients. Some local health committees or traditional Chinese medicine administrations recommend a variety of other ways of using traditional aromatic Chinese herbs to prevent and cure COVID-19. These involve external fumigation, use of moxibustion, and wearing of sachet. The efficacy of aromatic Chinese herbs plays a decisive role in the prevention and treatment of COVID-19. The unique properties, chemical composition, and mechanism of action of aromatic Chinese herbs are worthy of extensive and in-depth experimental and clinical research. The findings are expected to provide a reference for follow-up treatment of novel coronavirus and the development of corresponding drugs. In 2003, Dayuan-Yin produced excellent results in the treatment of the SARS virus. Individually, 112 confirmed cases were administered this drug between January and April 2003, and more than 93.7% of the patients showed noticeable mitigation of the symptoms, as well as recovery. Dayuan-Yin also was selected as one of the nationally recommended prescriptions for the COVID-19. Based on the national recommendation of Dayuan-Yin prescription, this review discusses the role of volatile components in the prevention and treatment of COVID-19, and speculates the possible mechanism of action, so as to provide a basis for the prevention and treatment of COVID-19.

摘要

芳香类中药自古以来就被用于预防瘟疫。中医在疫病防治方面具有独特优势。根据国家卫生健康委《新型冠状病毒肺炎诊疗方案(试行第七版)》中的中医治疗方案,在新冠肺炎确诊患者的医学观察期、临床治疗期及康复期,选用富含芳香类中药的中成药或方剂进行防治。一些地方卫生健康委或中医药管理部门还推荐了多种运用传统芳香类中药防治新冠肺炎的其他方法,包括熏香、艾灸、佩戴香囊等。芳香类中药的功效在新冠肺炎防治中起决定性作用。其独特的性质、化学成分及作用机制值得进行广泛深入的实验和临床研究。研究结果有望为新型冠状病毒后续治疗及相应药物研发提供参考。2003年,大元饮在治疗非典病毒方面取得了良好效果。2003年1月至4月间,112例确诊病例单独使用了该药物,超过93.7%的患者症状明显缓解并康复。大元饮还被选为新冠肺炎全国推荐方剂之一。基于大元饮方剂的全国推荐,本综述探讨了挥发性成分在新冠肺炎防治中的作用,并推测其可能的作用机制,为新冠肺炎防治提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c21/7546797/5c2de59ad5fe/fphar-11-583651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c21/7546797/5c2de59ad5fe/fphar-11-583651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c21/7546797/5c2de59ad5fe/fphar-11-583651-g001.jpg

相似文献

1
The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic.中药大元阴挥发性成分在抗击新冠疫情中的重要作用
Front Pharmacol. 2020 Sep 25;11:583651. doi: 10.3389/fphar.2020.583651. eCollection 2020.
2
[Study on medication laws of traditional Chinese medicine of 48 patients with coronavirus disease 2019 in intensive care unit based on data mining].基于数据挖掘的48例新型冠状病毒肺炎重症监护病房患者中医用药规律研究
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Oct;33(10):1175-1180. doi: 10.3760/cma.j.cn121430-20210826-01285.
3
[Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].[中医药在新型冠状病毒肺炎分期防治中的特性与疗效分析]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1253-1258. doi: 10.19540/j.cnki.cjcmm.20200225.501.
4
[Treatment strategy and thought on classical herbal formulae for coronavirus disease 2019].[2019冠状病毒病经典方剂治疗策略与思路]
Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(2):494-503. doi: 10.19540/j.cnki.cjcmm.20200603.501.
5
Analysis of Chinese Herbal Formulae Recommended for COVID-19 in Different Schemes in China: A Data Mining Approach.分析中国不同方案中推荐用于 COVID-19 的中草药配方:一种数据挖掘方法。
Comb Chem High Throughput Screen. 2021;24(7):957-967. doi: 10.2174/1386207323666201001114101.
6
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].[中草药及其活性成分干预人类冠状病毒的研究进展]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501.
7
[Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining].基于数据挖掘的中医治疗新型冠状病毒肺炎用药特点分析
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):260-269. doi: 10.3785/j.issn.1008-9292.2020.03.14.
8
Analysis on application law of dampness-removing traditional Chinese medicines in treatment of coronavirus disease 2019.祛湿类中药治疗新型冠状病毒肺炎的应用规律分析
Chin Herb Med. 2021 Oct;13(4):518-524. doi: 10.1016/j.chmed.2021.09.011. Epub 2021 Oct 1.
9
Reflections on treatment of COVID-19 with traditional Chinese medicine.关于用中医药治疗新型冠状病毒肺炎的思考
Chin Med. 2020 Sep 3;15:94. doi: 10.1186/s13020-020-00375-1. eCollection 2020.
10
[Analysis of prescription and medication rules of traditional Chinese medicine in the treatment of the coronavirus disease 2019 based on traditional Chinese medicine inheritance support platform].基于中医传承辅助平台的2019冠状病毒病中医用药规律分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 May;34(5):454-458. doi: 10.3760/cma.j.cn121430-20210907-01342.

引用本文的文献

1
Inhibition Effects of Patchouli Alcohol, Carvacrol, p-Cymene, Eucalyptol and Their Formulations Against Influenza Virus Pneumonia Through TLR4/NF-κB/NLRP3 Signaling Pathway.广藿香醇、香芹酚、对伞花烃、桉叶油素及其制剂通过TLR4/NF-κB/NLRP3信号通路对流感病毒肺炎的抑制作用
Chem Biol Drug Des. 2025 Aug;106(2):e70150. doi: 10.1111/cbdd.70150.
2
Aromatic Molecular Compatibility Attenuates Influenza Virus-Induced Acute Lung Injury via the Lung-Gut Axis and Lipid Droplet Modulation.芳香族分子相容性通过肺-肠轴和脂滴调节减轻流感病毒诱导的急性肺损伤。
Pharmaceuticals (Basel). 2025 Mar 26;18(4):468. doi: 10.3390/ph18040468.
3

本文引用的文献

1
Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome.2019冠状病毒病(COVID-19):细胞因子风暴、高炎症表型与急性呼吸窘迫综合征
Genes Dis. 2020 Dec;7(4):520-527. doi: 10.1016/j.gendis.2020.06.009. Epub 2020 Jun 29.
2
The use of dexamethasone in the treatment of COVID-19.地塞米松在新型冠状病毒肺炎治疗中的应用。
Ann Med Surg (Lond). 2020 Jul 9;56:218-219. doi: 10.1016/j.amsu.2020.07.004. eCollection 2020 Aug.
3
Dexamethasone for COVID-19: data needed from randomised clinical trials in Africa.
Transcriptomic and metabolomic study of the biosynthetic pathways of bioactive components in Amomum tsaoko fruits.
草果果实中生物活性成分生物合成途径的转录组学和代谢组学研究
BMC Plant Biol. 2025 Feb 18;25(1):212. doi: 10.1186/s12870-025-06239-w.
4
The Impact of Traditional Chinese Herbal Decoctions Combined with Rehabilitation Therapy on Pulmonary Function and Respiratory Muscle Strength in COVID-19 Recovery Patients.中药汤剂联合康复治疗对新型冠状病毒肺炎康复患者肺功能及呼吸肌力量的影响
Infect Drug Resist. 2024 Oct 23;17:4617-4624. doi: 10.2147/IDR.S477984. eCollection 2024.
5
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.关于COVID-19的药物制剂、免疫疗法和支持性疗法的全面综述。
Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8.
6
Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial.探讨不同剂量清肺大院颗粒的效用:一项多中心、随机、双盲、安慰剂对照试验。
Aging (Albany NY). 2024 Feb 26;16(5):4503-4517. doi: 10.18632/aging.205601.
7
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy.用于增强肿瘤免疫治疗效果的中药活性成分。
Front Immunol. 2023 Mar 10;14:1133050. doi: 10.3389/fimmu.2023.1133050. eCollection 2023.
8
Molecular Mechanism of Dayuan Decoction in the Treatment of Fever Based on Network Pharmacology.基于网络药理学的大元汤治疗发热的分子机制。
Comput Math Methods Med. 2022 Mar 25;2022:7422383. doi: 10.1155/2022/7422383. eCollection 2022.
9
Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic.社论:对2019年冠状病毒病大流行的民族药理学反应
Front Pharmacol. 2021 Dec 3;12:798674. doi: 10.3389/fphar.2021.798674. eCollection 2021.
10
A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19.天然产物综述:它们对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的影响及其作为先导化合物在发现治疗2019冠状病毒病(COVID-19)药物中的应用。
Med Chem Res. 2022;31(1):40-51. doi: 10.1007/s00044-021-02826-2. Epub 2021 Dec 2.
用于治疗新冠肺炎的地塞米松:非洲随机临床试验所需数据。
Lancet Glob Health. 2020 Sep;8(9):e1125-e1126. doi: 10.1016/S2214-109X(20)30318-1. Epub 2020 Jul 14.
4
Citrus reticulata peel oil as an antiatherogenic agent: Hypolipogenic effect in hepatic cells, lipid storage decrease in foam cells, and prevention of LDL oxidation.柑橘皮油作为一种抗动脉粥样硬化剂:在肝细胞中的降血脂作用、泡沫细胞中脂质储存减少和 LDL 氧化的预防。
Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1590-1599. doi: 10.1016/j.numecd.2020.04.033. Epub 2020 May 12.
5
Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking.基于网络药理学和分子对接的大uan饮治疗新型冠状病毒肺炎的机制
Chin Med. 2020 Jun 12;15:62. doi: 10.1186/s13020-020-00346-6. eCollection 2020.
6
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.中国治疗新型冠状病毒肺炎(COVID-19)的潜在药物。
Virus Res. 2020 Sep;286:198057. doi: 10.1016/j.virusres.2020.198057. Epub 2020 Jun 9.
7
The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic.中药“清肺排毒汤”多糖在抗击 COVID-19 大流行中的重要作用。
Carbohydr Polym. 2020 Jul 15;240:116346. doi: 10.1016/j.carbpol.2020.116346. Epub 2020 Apr 22.
8
Retinal findings in patients with COVID-19.新型冠状病毒肺炎患者的视网膜病变
Lancet. 2020 May 23;395(10237):1610. doi: 10.1016/S0140-6736(20)31014-X. Epub 2020 May 12.
9
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.干扰素 beta-1b、洛匹那韦利托那韦和利巴韦林三联治疗住院 COVID-19 患者:一项开放标签、随机、2 期试验。
Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.
10
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.模拟新型冠状病毒肺炎(COVID-19)在金黄地鼠模型中的临床和病理表现:对疾病发病机制和传染性的影响。
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446. doi: 10.1093/cid/ciaa325.